Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Pfizer is conducting a Phase 1 study of PF-07799544 as a monotherapy or in combination for advanced solid tumors, including melanoma and glioma, with recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Differentiated Thyroid Cancer
• Glioma
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• PF-07799544

Snippet

Sponsor: Pfizer | Conditions: Melanoma, Glioma | Phase 1 | Status: RECRUITING